§ BIOTECHNOLOGY
USD · BiotechnologyBBIO
BRIDGEBIO PHARMA INC
USDSector · BiotechnologyBeta · 1.15
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
OPEN 67.10HIGH 68.68LOW 66.2352W 28.32 — 84.94
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
269 increased/new, 170 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/B | 150.71 | EPS (TTM) | -3.78 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| BlackRock, Inc. | 14.2M | 0.0% | −2% |
| Kohlberg Kravis Roberts & Co. L.P. | 13.3M | 18.4% | ±0% |
| JANUS HENDERSON GROUP PLC | 13.2M | n/a | +20% |
| Viking Global | 11.8M | 2.5% | −18% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 8.1M | n/a | n/a |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.8M | n/a | n/a |
◇ AC INTELLIGENCE
Top institutional owners for BBIO as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER55.1% · 341 holders
QUALITY / COMPOUNDER23.3% · 37 holders
PASSIVE / INDEX13.8% · 11 holders
DEALER / BANK12.1% · 40 holders
TACTICAL / MACRO8.5% · 6 holders
INCOME / DEFENSIVE2.7% · 18 holders
ACTIVIST1.3% · 1 holder
SYSTEMATIC / QUANT1.0% · 10 holders
GROWTH / MOMENTUM0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for BBIO in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention BBIO yet.